RBC Bioscience (Taiwan) Performance
| 6848 Stock | 16.40 0.50 2.96% |
The firm owns a Beta (Systematic Risk) of 0.13, which implies not very significant fluctuations relative to the market. As returns on the market increase, RBC Bioscience's returns are expected to increase less than the market. However, during the bear market, the loss of holding RBC Bioscience is expected to be smaller as well. At this point, RBC Bioscience has a negative expected return of -0.0884%. Please make sure to check RBC Bioscience's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if RBC Bioscience performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days RBC Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, RBC Bioscience is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
RBC |
RBC Bioscience Relative Risk vs. Return Landscape
If you would invest 1,750 in RBC Bioscience on October 29, 2025 and sell it today you would lose (110.00) from holding RBC Bioscience or give up 6.29% of portfolio value over 90 days. RBC Bioscience is generating negative expected returns and assumes 1.8154% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than RBC, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
RBC Bioscience Target Price Odds to finish over Current Price
The tendency of RBC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 16.40 | 90 days | 16.40 | about 92.39 |
Based on a normal probability distribution, the odds of RBC Bioscience to move above the current price in 90 days from now is about 92.39 (This RBC Bioscience probability density function shows the probability of RBC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon RBC Bioscience has a beta of 0.13. This suggests as returns on the market go up, RBC Bioscience average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding RBC Bioscience will be expected to be much smaller as well. Additionally RBC Bioscience has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. RBC Bioscience Price Density |
| Price |
Predictive Modules for RBC Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as RBC Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.RBC Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. RBC Bioscience is not an exception. The market had few large corrections towards the RBC Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold RBC Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of RBC Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 0.44 | |
Ir | Information ratio | -0.1 |
RBC Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RBC Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RBC Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RBC Bioscience generated a negative expected return over the last 90 days |
Things to note about RBC Bioscience performance evaluation
Checking the ongoing alerts about RBC Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RBC Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RBC Bioscience generated a negative expected return over the last 90 days |
- Analyzing RBC Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RBC Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining RBC Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RBC Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RBC Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RBC Bioscience's stock. These opinions can provide insight into RBC Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for RBC Stock Analysis
When running RBC Bioscience's price analysis, check to measure RBC Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RBC Bioscience is operating at the current time. Most of RBC Bioscience's value examination focuses on studying past and present price action to predict the probability of RBC Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RBC Bioscience's price. Additionally, you may evaluate how the addition of RBC Bioscience to your portfolios can decrease your overall portfolio volatility.